- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03971526
Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke
Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a New Highly Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke
Magnetic resonance imaging (MRI) is the diagnostic cornerstone for precisely identifying acute ischaemic strokes and locating vascular occlusions.
It was observed that a post-contrast three-dimensional turbo-spin-echo T1weighted sequence showed striking post-contrast vascular hyperintensities (PCVH) in ischaemic territories. The aim is to evaluate the prevalence and the meaning of this finding.
This study included 130 consecutive patients admitted for acute ischaemic stroke with a 3-T MRI performed in the first 12 h of symptom onset from September 2014 through September 2016. Two neuroradiologists blinded to clinical data analysed the first MRI assessments.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Patients aged 18 and older at onset of an acute ischaemic stroke
- Availability of at least one pre-therapeutic MRI performed in our centre within 12 h of stroke onset, including a post-contrast 3D TSE T1-weighted sequence.
Exclusion criteria:
- Patients with posterior fossa strokes
- Patients with known intracranial vasculitis or MoyaMoya disease
- Presence of severe MR imaging artefacts preventing correct interpretation
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
overal survival
Time Frame: 7 years
|
from the AR-PML diagnosis date to that of death or censored on 31 December 2015
|
7 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 29426989
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Ischaemic Stroke
-
Institut National de la Santé Et de la Recherche...Fondation de l'AvenirUnknown
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Aurum Biosciences LtdUnknown
-
AstraZenecaCompletedAcute Ischaemic Stroke | Transient Ischaemic AttackBelgium, France, Italy, Spain, Sweden, Thailand, Germany, Korea, Republic of, Brazil, Hungary, India, Mexico, Vietnam, China, Taiwan, Hong Kong, Slovakia, Australia, Poland, Saudi Arabia, Ukraine, Canada, Russian Federation, Bulgaria, R... and more
-
AstraZenecaCompletedAcute Ischaemic Stroke | Transient Ischaemic AttackSweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
-
Zhujiang HospitalRecruitingDepression | Acute Ischaemic StrokeChina
-
West China HospitalNational Natural Science Foundation of China; Chengdu University of Traditional... and other collaboratorsCompletedSevere Ischaemic Stroke | Malignant Ischaemic StrokeChina
-
The University of Hong KongQueen Mary Hospital, Hong Kong; Ruttonjee Hospital, Hong KongCompletedAcute Ischaemic StrokeHong Kong
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
Tasly Biopharmaceuticals Co., Ltd.CompletedAcute Ischaemic StrokeChina
Clinical Trials on MRI images review
-
Centre Hospitalier Universitaire, AmiensCompletedMagnetic Resonance Imaging
-
University of ArkansasSiemens Molecular ImagingTerminatedMultiple MyelomaUnited States
-
Peking University Third HospitalRecruitingFemoral Acetabular ImpingementChina
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Northwell HealthGE Healthcare; Arterys, Inc.Active, not recruitingCardiac DiseaseUnited States
-
Peking University Third HospitalEnrolling by invitationAnterior Cruciate Ligament InjuriesChina
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingProstate CarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Ege UniversityCompletedMeasurements in Mandibular SymphysisTurkey
-
Fundación Pública Andaluza para la gestión de la...UnknownRenal Cell Carcinoma | Venous Thromboses | Three-DimensionalSpain